New Advancements in Whole Genome Sequencing with Callisto™
BOSTON – Volta Labs, a pioneering name in the field of next-generation sequencing (NGS) automation, has recently unveiled significant developments to its Callisto™ Sample Preparation Platform. This enhancement enables the platform to provide fully automated DNA library preparation compatible with any sequencer and chemistry employed in whole-genome sequencing, marking a notable step forward in genomic research.
What Does Callisto™ Offer?
One of the standout features of the upgraded Callisto platform is the introduction of seven validated WGS DNA applications. Researchers and laboratories can now experience a streamlined process with an app-based system designed for flexibility and quality. Callisto supports various platforms from leading companies in the industry, such as Illumina, Oxford Nanopore Technologies (ONT), Element Biosciences, and more.
Key Features of the New Launch
The Callisto platform enhances laboratory workflows with the following capabilities:
- Seven validated WGS DNA Applications, including PCR-free short-read and long-read options.
- Pre-validated kits backed by user experience, aimed specifically for Short-Read Sequencing.
Advantages of the New Platform
There are several noteworthy reasons why this advancement is significant:
Universal Access Without Retraining
The Callisto platform offers access to over seven validated WGS applications across five short-read kits and two long-read kits. This flexibility means labs can easily implement the solutions without extensive retraining, allowing them to simply load the kit and start the process.
Accelerated Time to Results
With pre-validated methods, laboratories can transition to production in a matter of weeks, bypassing the lengthy development and optimization time of approximately four to six months. Such efficiency can reduce hands-on time significantly, with estimates indicating cuts of 75% to 80% and a 50% to 70% decrease in time-to-first-data.
Confidence in Quality
The system achieves a low cross-site coefficient of variation (CV) of ?5% for key quality control metrics, ensuring that high-quality, reproducible whole-genome libraries are maintained across different laboratories.
Company Initiatives and Engagements
As part of its commitment to showcasing innovations, Volta Labs will be holding a workshop during a renowned conference, where they’ll discuss the practical implementation of the Callisto platform. This session is titled "Reimagining NGS Prep: End-to-End Automation for Faster Clinical Insights" and aims to shed light on real-world applications of the platform in clinical settings.
Dr. Lennart Kester from the Prinses Máxima Center for Pediatric Oncology will present how his team leverages Callisto to enhance whole-genome sequencing workflows, exemplifying the platform's role in delivering rapid clinical insights.
About Volta Labs
Since its establishment in 2018, Volta Labs has been at the forefront of genomic sample preparation innovation. With a mission to transform traditional laboratory workflows through automation, Volta's Callisto platform represents a significant leap towards more efficient, scalable, and reproducible genomics processes. By prioritizing ease of use and reliability, Volta Labs empowers laboratories to achieve high-quality results without the usual complexities associated with genomic research.
Contact Information
For further details regarding availability and pricing of the Callisto™ platform and its applications, Volta Labs encourages interested parties to reach out for app bundles and promotional packages tailored to their needs.
Frequently Asked Questions
What is the main advantage of the Callisto™ platform?
The main advantage is its ability to deliver fully automated DNA library preparation across multiple sequencers and chemistries, enhancing flexibility and efficiency in labs.
How many DNA Applications does Callisto™ support?
Callisto™ currently supports seven validated WGS DNA applications, catering to both short-read and long-read workflows.
Can labs use Callisto™ without extensive retraining?
Yes, labs can use Callisto™ with minimal retraining, as it allows for immediate integration into existing workflows with its user-friendly design.
What types of sequencing platforms are compatible with Callisto™?
Callisto™ is compatible with a range of platforms, including those from Illumina, Oxford Nanopore Technologies (ONT), and PacBio, among others.
Where can I learn more about Volta Labs' products?
For more information about Volta Labs and its offerings, please visit their official website.
